sample review
- Cell Sciences bovine plasminogen was used to perform vascular embolism model establishment in order to show that obstructed blood vessels could be targeted by shear-activated nanotherapeutics.
- Cell Sciences tPA was used to perform nanoparticle function analysis in order to show that obstructed blood vessels could be targeted by shear-activated nanotherapeutics.
- Cell Sciences Eli-pair kit was used to quantify the syndecan-1 in order to demonstrate that heparanase can promote expression of syndecan-1 in the nucleus.
- Cell Sciences B-A38 (Syndecan-1) antibody was used in western blot in order to demonstrate that heparanase can promote expression of syndecan-1 in the nucleus.
- Cell Sciences rat anti-mouse Ly-6G antibody was used to perform immunohistochemistry in order to show that the mice with decay-accelerating factor-deficient T cells can develop focal and segmental glomerulosclerosis easily.
- Cell Sciences IL-15 (final concentration of 5 ng/mL) was used to treat cells in order to test the effects of IL-7/IL-15, IFN-alpha, anti-ICOS, and anti-CD28 on antigen-specific T cell responses in patients infected with HCV or HIV
- Cell Sciences IL-7 (final concentration of 5 ng/mL) was used to treat cells in order to test the effects of IL-7/IL-15, IFN-alpha, anti-ICOS, and anti-CD28 on antigen-specific T cell responses in patients infected with HCV or HIV
- Cell Sciences rabbit polyclonal anti-MIF antibody was used in immunohistochemistry to study the role of the role of MIF in bladder cancer initiation and progression.
- Cell Sciences anti-Gp130 antibody BR-3 was used in human breast cancer cells and in blocking expriments to study the role for IL-6 in driving Stat3 activation in breast cancer.
- Cell Sciences anti-IL-6 antibody (which was in ELISA kit) and anti-IL-6-blocking antibody 522 were used in human breast cancer cells, and which used in ELISA and blocking expriments to study the role for IL-6 in driving Stat3 activation in breast cancer.